tiprankstipranks
Trending News
More News >
CorVel Corporation (CRVL)
NASDAQ:CRVL
US Market
Advertisement

CorVel (CRVL) AI Stock Analysis

Compare
175 Followers

Top Page

CRVL

CorVel

(NASDAQ:CRVL)

Rating:66Neutral
Price Target:
$95.00
▲(14.75% Upside)
CorVel Corporation's strong financial performance is the primary driver of its stock score, reflecting robust revenue growth and financial stability. However, technical indicators suggest bearish momentum, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.
Positive Factors
Revenue Growth
Consistent revenue growth indicates effective market penetration and product adoption, supporting long-term business expansion and stability.
Cash Flow Generation
Strong cash flow generation enhances financial flexibility, enabling strategic investments and resilience against economic fluctuations.
Leverage Management
Prudent leverage management ensures financial stability, reducing risk and supporting sustainable growth through economic cycles.
Negative Factors
Operational Efficiency Volatility
Volatility in operational efficiency can impact profitability, indicating potential challenges in cost management and margin sustainability.
Free Cash Flow Fluctuations
Fluctuations in free cash flow growth could signal inconsistent cash management, affecting long-term investment capability and financial planning.
Stock Incentive Plan
While aligning interests with shareholders, stock incentives can dilute existing equity, potentially impacting shareholder value if not managed carefully.

CorVel (CRVL) vs. SPDR S&P 500 ETF (SPY)

CorVel Business Overview & Revenue Model

Company DescriptionCorVel Corporation (CRVL) is a national provider of risk management solutions, specializing in the management of workers' compensation, auto, and general liability claims. The company operates primarily in the healthcare sector, offering a suite of services including medical management, pharmacy benefits management, and data analytics. CorVel's core products are designed to enhance the efficiency and effectiveness of claims processing, reduce costs for employers and insurers, and improve outcomes for injured workers.
How the Company Makes MoneyCorVel generates revenue through a diversified model that includes fees for its various services. Key revenue streams comprise the management of workers' compensation claims, which includes medical and non-medical cost containment services, and the provision of pharmacy benefit management services. The company also earns income from its advanced data analytics and technology solutions that assist clients in making informed decisions regarding risk management. Significant partnerships with insurance companies, third-party administrators, and self-insured employers enhance CorVel's ability to capture a larger market share and drive revenue growth. Additionally, the company benefits from economies of scale as it expands its client base, allowing it to optimize operational efficiencies and increase profitability.

CorVel Financial Statement Overview

Summary
CorVel Corporation exhibits robust financial health with strong revenue and profit growth, efficient leverage management, and solid cash flow generation. While minor fluctuations in operational efficiency and free cash flow growth warrant monitoring, the company's overall financial trajectory is positive, supporting its competitive position in the insurance brokerage industry.
Income Statement
87
Very Positive
CorVel has shown a strong upward trajectory in revenue growth, with revenue increasing consistently over the past years. The company's gross profit and net profit margins are healthy, demonstrating effective cost management and profitability. However, the slight fluctuation in EBIT and EBITDA margins suggests potential volatility in operational efficiency.
Balance Sheet
92
Very Positive
CorVel maintains a robust financial position with a very low debt-to-equity ratio, indicating prudent leverage management. The company has a strong equity ratio, suggesting financial stability and a solid asset base. High return on equity further emphasizes the company's efficiency in generating returns for shareholders.
Cash Flow
85
Very Positive
The company has demonstrated strong free cash flow generation and growth, supported by consistent operating cash flows. The operating cash flow to net income ratio indicates effective conversion of income into cash, though minor fluctuations in free cash flow growth suggest potential investment or expenditure variations.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue895.59M895.59M795.31M718.56M646.23M552.64M
Gross Profit209.73M209.73M171.69M158.26M152.11M123.62M
EBITDA150.36M150.36M121.35M109.67M108.43M82.61M
Net Income95.17M95.17M76.25M66.36M66.41M46.36M
Balance Sheet
Total Assets545.98M545.98M454.68M393.92M415.25M424.76M
Cash, Cash Equivalents and Short-Term Investments170.58M170.58M105.56M71.33M97.50M139.72M
Total Debt19.95M19.95M31.40M33.76M43.14M54.66M
Total Liabilities223.99M223.99M207.03M191.75M202.85M204.36M
Stockholders Equity321.99M321.99M247.65M202.18M212.40M220.40M
Cash Flow
Free Cash Flow91.56M91.56M70.00M55.97M37.40M77.14M
Operating Cash Flow127.31M127.31M99.24M82.29M67.22M94.38M
Investing Cash Flow-35.76M-35.76M-29.24M-26.32M-29.82M-17.24M
Financing Cash Flow-26.54M-26.54M-35.76M-82.14M-79.61M-20.64M

CorVel Technical Analysis

Technical Analysis Sentiment
Negative
Last Price82.79
Price Trends
50DMA
90.47
Negative
100DMA
99.66
Negative
200DMA
106.48
Negative
Market Momentum
MACD
-1.50
Positive
RSI
37.19
Neutral
STOCH
17.88
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CRVL, the sentiment is Negative. The current price of 82.79 is below the 20-day moving average (MA) of 88.25, below the 50-day MA of 90.47, and below the 200-day MA of 106.48, indicating a bearish trend. The MACD of -1.50 indicates Positive momentum. The RSI at 37.19 is Neutral, neither overbought nor oversold. The STOCH value of 17.88 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CRVL.

CorVel Risk Analysis

CorVel disclosed 32 risk factors in its most recent earnings report. CorVel reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

CorVel Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$30.85B26.9711.27%0.66%11.68%-0.17%
69
Neutral
$514.35M17.8518.06%2.75%5.58%28.75%
69
Neutral
$506.65M16.6918.06%2.88%5.58%28.75%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
66
Neutral
$4.39B44.1333.25%12.46%29.16%
55
Neutral
$1.34B58.678.26%17.86%-77.16%
45
Neutral
$3.69B-2.91%11.43%64.61%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CRVL
CorVel
82.79
-24.22
-22.63%
BRO
Brown & Brown
90.88
-12.63
-12.20%
CRD.A
Crawford & Company A
10.38
0.02
0.19%
CRD.B
Crawford & Company B
9.93
-0.67
-6.32%
BWIN
Baldwin Insurance Group
30.08
-19.10
-38.84%
TWFG
TWFG, Inc. Class A
23.79
-2.86
-10.73%

CorVel Corporate Events

Shareholder MeetingsBusiness Operations and Strategy
CorVel Holds 2025 Annual Stockholders Meeting
Neutral
Aug 13, 2025

On August 7, 2025, CorVel Corporation held its 2025 Annual Meeting of Stockholders, where shareholders voted on three key proposals. The election of six directors to serve until the 2026 meeting was conducted, with varying levels of support for each candidate. Additionally, the appointment of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2026, was ratified. Lastly, the 2025 Stock Incentive Plan was approved, indicating continued strategic focus on incentivizing performance and aligning interests with shareholders.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 10, 2025